Sign In
Buy RPRX
$53.57
+0.610 (+1.15%)
At Close: Jun 22, 2026
Warren Buffett Buys 2 Stocks, Adds to Chevron Stake in 3rd Quarter
06:41pm, Monday, 15'th Nov 2021
Warren Buffett (Trades, Portfolio)'s multibillion-dollar conglomerate, Berkshire Hathaway Inc. ( BRK.A , Financial)( BRK.B , Financial), disclosed its equity portfolio for the third quarter of 2021 on
Warren Buffett's Berkshire Hathaway reveals new bets on Floor & Decor and Royalty Pharma
04:46pm, Monday, 15'th Nov 2021
The famed investor's company also exited Merck and trimmed several holdings including Visa, Mastercard, and AbbVie.
Royalty Pharma plc (RPRX) CEO Pablo Legorreta on Q3 2021 Results - Earning Call Transcript
01:54pm, Wednesday, 10'th Nov 2021
Royalty Pharma plc (RPRX) CEO Pablo Legorreta on Q3 2021 Results - Earning Call Transcript
Royalty Pharma (RPRX) Tops Q3 Earnings and Revenue Estimates
09:57am, Wednesday, 10'th Nov 2021
Royalty Pharma (RPRX) delivered earnings and revenue surprises of 5.80% and 3.18%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Royalty Pharma Provides Unique Diversity To A Biopharma Portfolio
12:45pm, Wednesday, 27'th Oct 2021
RPRX buys royalties of high-profile assets.
Royalty Pharma to Announce Third-Quarter 2021 Financial Results on November 10, 2021
09:00am, Monday, 18'th Oct 2021
NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter of 2021 financial results on Wednesday, November 10, 2021 before the
Royalty Pharma Declares Fourth-Quarter 2021 Dividend
09:00am, Friday, 15'th Oct 2021
NEW YORK, Oct. 15, 2021 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2021 of $0.17 per Class A ordin
Top 3 undervalued US biotech stocks to buy
02:27pm, Tuesday, 12'th Oct 2021
With the US Q3 earnings season just getting started, there are a few biotech stocks that present an exciting opportunity for value investors. Some of these stocks look significantly undervalued after
Royalty Pharma to Present at Upcoming Investor Conferences
09:00am, Friday, 03'rd Sep 2021
NEW YORK, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of September:
Wall Street Journal Creates A Pitch In Favor Of Royalty Pharma
01:50pm, Tuesday, 17'th Aug 2021
Drug development, both a lucrative and a risky segment. Royalty Pharma plc (NASDAQ: RPRX) offers a middle ground for its investors.
Royalty Pharma's (RPRX) CEO Pablo Legorreta on Q2 2021 Results - Earnings Call Transcript
01:30pm, Wednesday, 11'th Aug 2021
Royalty Pharma's (RPRX) CEO Pablo Legorreta on Q2 2021 Results - Earnings Call Transcript
Royalty Pharma (RPRX) Q2 Earnings and Revenues Surpass Estimates
11:00am, Wednesday, 11'th Aug 2021
Royalty Pharma (RPRX) delivered earnings and revenue surprises of 1.43% and 0.10%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Royalty Pharma Q2 Earnings
07:38am, Wednesday, 11'th Aug 2021
Shares of Royalty Pharma (NASDAQ:RPRX) rose 3.8% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 26.26% year over year to $0.73, which beat
Royalty Pharma Reports Second Quarter 2021 Results
07:00am, Wednesday, 11'th Aug 2021
NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the second quarter of 2021 and raised full-year 2021 guidance for Adjusted Cash Recei
Royalty Pharma Declares Third-Quarter 2021 Dividend
09:00am, Friday, 16'th Jul 2021
NEW YORK, July 16, 2021 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2021 of $0.17 per class A ordina
